ReviewOrthopedic research and reviews2026
Brace Dose in Scoliosis: Measurement, Monitoring, and Clinical Decision-Making-A Narrative Review.
Review in Orthopedic research and reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adolescent idiopathic scoliosis bracing is best conceptualized as a dose-dependent therapy in which clinical benefit depends on the delivered, rather than prescribed, corrective exposure. This narrative review synthesizes post-2015 evidence to present a clinically oriented framework for "precision bracing" that links brace prescription to objectively measured delivered dose and subsequent clinical response. We summarize evidence that bracing reduces progression risk in skeletally immature patients, while highlighting the efficacy-effectiveness gap driven by incomplete adherence. We review objective adherence monitoring technologies, focusing on temperature-based data loggers and emerging force or pressure sensing approaches, and explain how objective dosing data refine outcome interpretation by distinguishing undertreatment from true treatment failure. We conceptualize brace dose as a multidimensional construct that includes quantity (objectively measured wear time), pattern (regularity), and correction-related indicators (including in-brace and early out-of-brace radiographic metrics and, when available, interface force surrogates). We synthesize key effect modifiers, including skeletal maturity, curve magnitude and phenotype, early radiographic response, and contextual determinants of achieved wear time. We translate this evidence into a practical clinical framework for risk stratification, brace schedule selection, objective monitoring, early reassessment, and escalation when delivered dose is inadequate or response is unacceptable We conclude by outlining research priorities for standardized reporting of delivered dose, pragmatic trials embedded in routine care, and core outcome sets that integrate radiographic and patient-reported outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.